301267 华厦眼科
已收盘 12-17 15:00:00
资讯
新帖
简况
华厦眼科:引进国际前沿诊疗新技术新设备
证券之星 · 12-16 11:37
华厦眼科:引进国际前沿诊疗新技术新设备
华厦眼科(301267)披露2025年中期分红派息实施公告,12月15日股价下跌0.97%
证券之星 · 12-15 22:18
华厦眼科(301267)披露2025年中期分红派息实施公告,12月15日股价下跌0.97%
华厦眼科:公司经营一切正常不存在退市风险
证券之星 · 12-05
华厦眼科:公司经营一切正常不存在退市风险
华厦眼科:通过自建及并购推进全国布局
证券之星 · 12-04
华厦眼科:通过自建及并购推进全国布局
华厦眼科:构建完善近视防控体系
证券之星 · 12-02
华厦眼科:构建完善近视防控体系
华厦眼科(301267)3.2亿股限售股将于11月7日解禁,占总股本38.05%
证券之星 · 11-07
华厦眼科(301267)3.2亿股限售股将于11月7日解禁,占总股本38.05%
华厦眼科:积极举办及参与国内外眼科学术交流活动
证券之星 · 11-06
华厦眼科:积极举办及参与国内外眼科学术交流活动
华厦眼科(301267)披露首次公开发行前已发行股份解除限售并上市流通的提示性公告,11月05日股价上涨0.52%
证券之星 · 11-05
华厦眼科(301267)披露首次公开发行前已发行股份解除限售并上市流通的提示性公告,11月05日股价上涨0.52%
华厦眼科(301267)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 10-30
华厦眼科(301267)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
图解华厦眼科三季报:第三季度单季净利润同比下降2.37%
证券之星 · 10-29
图解华厦眼科三季报:第三季度单季净利润同比下降2.37%
股市必读:华厦眼科(301267)10月10日董秘有最新回复
证券之星 · 10-13
股市必读:华厦眼科(301267)10月10日董秘有最新回复
华厦眼科:暂未收到苏庆灿相关进一步通知
证券之星 · 10-10
华厦眼科:暂未收到苏庆灿相关进一步通知
华厦眼科:引进蔡司新一代机器人全飞秒VISUMAX800
证券之星 · 10-10
华厦眼科:引进蔡司新一代机器人全飞秒VISUMAX800
华厦眼科:已与智能眼镜生产企业建立合作
中金财经 · 09-30
华厦眼科:已与智能眼镜生产企业建立合作
华厦眼科:9月26日接受机构调研,中信证券、上海证券等多家机构参与
证券之星 · 09-28
华厦眼科:9月26日接受机构调研,中信证券、上海证券等多家机构参与
9月11日华厦眼科涨6.29%,中信建投轮换混合A基金重仓该股
证券之星 · 09-11
9月11日华厦眼科涨6.29%,中信建投轮换混合A基金重仓该股
华厦眼科股价报20.45元 屈光手术收入增速保持两位数
市场资讯 · 09-02
华厦眼科股价报20.45元 屈光手术收入增速保持两位数
华厦眼科(301267)2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 08-26
华厦眼科(301267)2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
华厦眼科(301267.SZ):上半年净利润2.82亿元,同比增长6.20%
格隆汇 · 08-24
华厦眼科(301267.SZ):上半年净利润2.82亿元,同比增长6.20%
华厦眼科:发布对外投资管理制度
金融界快讯 · 08-24
华厦眼科:发布对外投资管理制度
加载更多
公司概况
公司名称:
华厦眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-11-07
主营业务:
华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。报告期内,华厦眼科获得国家眼部疾病临床医学研究中心授予的“中国眼科病理联盟COPA中心级单位”,厦门眼科中心副院长吴护平教授团队的科研课题《重大角膜及眼表疾病的关键诊疗技术和规范建设》斩获“厦门市科学技术进步奖二等奖”,厦门眼科中心业务副院长刘旭阳教授团队的科研课题《眼病的分子遗传学系列研究》获“福建医学科技奖三等奖”及“厦门市科学技术进步三等奖”。
发行价格:
50.88
{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":18.43,"timestamp":1765955025000,"preClose":18.36,"halted":0,"volume":4067800,"delay":0,"changeRate":0.0038,"floatShares":648000000,"shares":840000000,"eps":0.5256,"marketStatus":"已收盘","change":0.07,"latestTime":"12-17 15:00:00","open":18.3,"high":18.5,"low":18.15,"amount":74686500,"amplitude":0.0191,"askPrice":18.43,"askSize":99,"bidPrice":18.42,"bidSize":29,"shortable":0,"etf":0,"ttmEps":0.5256,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":18.36,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":20.2,"lowLimit":16.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.57,"roa":"--","peRate":35.064688,"roe":"7.36%","epsLYR":0.51,"committee":-0.159004,"marketValue":15481000000,"turnoverRate":0.0063,"status":0,"floatMarketCap":11951000000},"requestUrl":"/m/hq/s/301267","defaultTab":"news","newsList":[{"id":"2591672222","title":"华厦眼科:引进国际前沿诊疗新技术新设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2591672222","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591672222?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:37","pubTimestamp":1765856233,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科12月16日在投资者关系平台上答复投资者关心的问题。作为国内大型眼科医疗连锁集团,华厦眼科始终秉持“精湛医术、合理收费、高尚医德,贴心服务,快捷方便,优雅环境”的经营理念,持续为患者提供专业、优质、收费合理的诊疗服务。再次感谢您对华厦眼科的支持!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600015399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2591642389","title":"华厦眼科(301267)披露2025年中期分红派息实施公告,12月15日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642389?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:18","pubTimestamp":1765808302,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘,华厦眼科报收于18.33元,较前一交易日下跌0.97%,最新总市值为153.97亿元。该股当日开盘18.39元,最高18.63元,最低18.29元,成交额达1.27亿元,换手率为1.06%。公司近日发布公告,披露2025年中期分红派息实施情况。根据公告,本次分红以公司总股本840,000,000股剔除回购股份7,527,840股后的832,472,160股为基数,向全体股东每10股派发现金红利0.90元(含税),合计派发74,922,494.40元。回购股份不参与分红,分配方案与董事会审议通过的一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2589897549","title":"华厦眼科:公司经营一切正常不存在退市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2589897549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589897549?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:52","pubTimestamp":1764939145,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科12月05日在投资者关系平台上答复投资者关心的问题。最近公司股价一路下跌,前几天看到证券软件公布的消息,是在2025年12月15日后调出创业板指数。公司经营一切正常,已连续多年保持盈利,上市以来公司每年实施现金分红,且正在实施2025年中期分红,不存在触及退市风险警示及其他风险警示的有关情形。再次感谢您对华厦眼科的支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500037038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2588884162","title":"华厦眼科:通过自建及并购推进全国布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884162?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:51","pubTimestamp":1764852696,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科(301267)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘:您好!请问公司线下的实体店的盈利模式是加盟的合作方式还是直营。华厦眼科回复:尊敬的投资者您好,感谢您对华厦眼科的关注。公司长期专注于眼科医疗服务,已经建立了全国连锁运营的诊疗服务体系。公司正按照发展战略规划,通过自建及并购方式,稳步推进全国医疗服务网络布局。再次感谢您对华厦眼科的支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2588087475","title":"华厦眼科:构建完善近视防控体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2588087475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588087475?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:12","pubTimestamp":1764659526,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科12月02日在投资者关系平台上答复投资者关心的问题。公司拥有由国际眼科科学院院士赵堪兴教授领衔的高水平专家团队,在儿童青少年常见及疑难眼病、儿童青少年近视防控领域具备丰富的临床经验。再次感谢您对华厦眼科的支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200016984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2581383047","title":"华厦眼科(301267)3.2亿股限售股将于11月7日解禁,占总股本38.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581383047","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581383047?lang=zh_cn&edition=full","pubTime":"2025-11-07 08:05","pubTimestamp":1762473958,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,华厦眼科于11月7日将有3.2亿股限售股份解禁,为公司首发原股东限售股份,占公司总股本38.05%。本次解禁后,公司还有1.92亿股限售股份,占总股本22.8%。华厦眼科主营业务:眼科医疗服务,向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务,同时还向社会大众提供眼疾、近视预防干预工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700005656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2581082146","title":"华厦眼科:积极举办及参与国内外眼科学术交流活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2581082146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581082146?lang=zh_cn&edition=full","pubTime":"2025-11-06 09:06","pubTimestamp":1762391174,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科11月05日在投资者关系平台上答复投资者关心的问题。与宝岛还有哪些交流华厦眼科回复:尊敬的投资者您好,感谢您对华厦眼科的关注。近年来,公司积极举办及参与国内外眼科学术交流活动,共同推进我国眼科临床诊疗技术、教学与科学研究发展。再次感谢您对华厦眼科的支持!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600005963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2581779869","title":"华厦眼科(301267)披露首次公开发行前已发行股份解除限售并上市流通的提示性公告,11月05日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779869","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581779869?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:39","pubTimestamp":1762353561,"startTime":"0","endTime":"0","summary":"公司近日发布关于首次公开发行前已发行股份解除限售并上市流通的提示性公告。本次解除限售股东为2户,分别为华厦医疗投资(厦门)有限公司和苏庆灿,解除限售股份数量合计511,170,000股,占公司总股本的60.8536%,限售期为公司股票上市之日起36个月。本次解除限售股份上市流通日为2025年11月7日。股东苏庆灿为公司董事长、总经理,其解除限售股份中实际可上市流通部分为其解除限售数量的25%,其余将转为高管锁定股。保荐机构对本次解除限售无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2579158127","title":"华厦眼科(301267)2025年三季报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579158127","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579158127?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:42","pubTimestamp":1761777768,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华厦眼科发布2025年三季报。截至本报告期末,公司营业总收入32.72亿元,同比上升2.83%,归母净利润4.34亿元,同比上升3.04%。按单季度数据看,第三季度营业总收入11.33亿元,同比上升0.13%,第三季度归母净利润1.52亿元,同比下降2.37%。本报告期华厦眼科公司应收账款体量较大,当期应收账款占最新年报归母净利润比达81.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000007095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"gpt_icon":0},{"id":"2579993718","title":"图解华厦眼科三季报:第三季度单季净利润同比下降2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579993718","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579993718?lang=zh_cn&edition=full","pubTime":"2025-10-29 02:51","pubTimestamp":1761677495,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科2025年三季报显示,公司主营收入32.72亿元,同比上升2.83%;归母净利润4.34亿元,同比上升3.04%;扣非净利润4.23亿元,同比上升1.65%;其中2025年第三季度,公司单季度主营收入11.33亿元,同比上升0.13%;单季度归母净利润1.52亿元,同比下降2.37%;单季度扣非净利润1.46亿元,同比上升0.2%;负债率23.95%,投资收益3139.61万元,财务费用3383.18万元,毛利率45.03%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900003228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"gpt_icon":0},{"id":"2575756412","title":"股市必读:华厦眼科(301267)10月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2575756412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575756412?lang=zh_cn&edition=full","pubTime":"2025-10-13 03:44","pubTimestamp":1760298255,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,华厦眼科报收于20.02元,上涨0.0%,换手率1.29%,成交量4.23万手,成交额8462.03万元。根据公开信息,苏庆灿于2023年12月6日被上海市监察委员会留置,2024年6月6日解除留置,但随即被公安机关采取监视居住措施。截至2025年10月,这一状态尚未有进一步的公开更新信息。截至目前,公司暂未收到进一步通知。再次感谢您对华厦眼科的支持!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2574770128","title":"华厦眼科:暂未收到苏庆灿相关进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2574770128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574770128?lang=zh_cn&edition=full","pubTime":"2025-10-10 16:00","pubTimestamp":1760083241,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科10月10日在投资者关系平台上答复投资者关心的问题。根据公开信息,苏庆灿于2023年12月6日被上海市监察委员会留置,2024年6月6日解除留置,但随即被公安机关采取监视居住措施。截至目前,公司暂未收到进一步通知。再次感谢您对华厦眼科的支持!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000022995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2574251148","title":"华厦眼科:引进蔡司新一代机器人全飞秒VISUMAX800","url":"https://stock-news.laohu8.com/highlight/detail?id=2574251148","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574251148?lang=zh_cn&edition=full","pubTime":"2025-10-10 11:33","pubTimestamp":1760067219,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科10月09日在投资者关系平台上答复投资者关心的问题。公司主营业务为眼科医疗服务,公司始终高度关注眼科诊疗新设备、新技术的发展和临床应用,积极引进包括蔡司新一代机器人全飞秒VISUMAX800 及新微创手术 SMILE Pro 技术等在内的前沿诊疗设备和技术,致力于为患者提供优质、前沿的诊疗服务。再次感谢您对华厦眼科的支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000014158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2571331392","title":"华厦眼科:已与智能眼镜生产企业建立合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2571331392","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571331392?lang=zh_cn&edition=full","pubTime":"2025-09-30 12:10","pubTimestamp":1759205409,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科(301267)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司有没有AI眼镜的研发布局?华厦眼科回复:尊敬的投资者您好,感谢您对华厦眼科的关注。公司主营业务为眼科医疗服务,公司始终关注AI眼镜相关技术、产品的发展,并已与部分智能眼镜生产企业建立合作,进一步挖掘智能眼镜在眼科医疗服务领域的应用潜力。再次感谢您对华厦眼科的支持!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20250930/31684221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301267","BK0236"],"gpt_icon":0},{"id":"2570841221","title":"华厦眼科:9月26日接受机构调研,中信证券、上海证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2570841221","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570841221?lang=zh_cn&edition=full","pubTime":"2025-09-28 19:30","pubTimestamp":1759059050,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年9月28日华厦眼科发布公告称公司于2025年9月26日接受机构调研,中信证券徐嘉琪、上海证券刘薇、渤银理财董泽正 吴桐乐、巨杉资产何川、朱雀基金徐睿潇、天津薪富阳投资王亚浩、中信建投刘慧彬、中金公司张一弛 李千翊、嘉实基金程佳、平安养老邵瑾良、东北证券文将儒、华安证券李雨涵、华泰证券杨昌源、平安证券王钰畅参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800009699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0405327148.USD","LU1997245177.USD","LU2148510915.USD","BK0188","LU1328615791.USD","BK0012","LU1255011170.USD","06030","BK0028","LU1997245094.SGD","BK0183","LU1794554557.SGD","BK0276","BK1521","BK0236","LU0405327494.USD","LU1997244956.HKD","600030","BK0196","BK1147","161027","301267","LU2289578879.USD","BK1516","LU1720050803.USD","LU1064131003.USD","LU1064130708.USD","LU1655091616.SGD","BK1564","LU2495084118.USD"],"gpt_icon":0},{"id":"2566950442","title":"9月11日华厦眼科涨6.29%,中信建投轮换混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566950442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566950442?lang=zh_cn&edition=full","pubTime":"2025-09-11 16:35","pubTimestamp":1757579716,"startTime":"0","endTime":"0","summary":"证券之星消息,9月11日华厦眼科涨6.29%创60日新高,收盘报21.98元,换手率7.12%,成交量23.4万手,成交额5.1亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为中信建投基金的中信建投轮换混合A。中信建投轮换混合A目前规模为8.66亿元,最新净值3.211,较上一交易日下跌0.13%,近一年上涨50.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100026272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0276","301267","601066"],"gpt_icon":0},{"id":"2564800554","title":"华厦眼科股价报20.45元 屈光手术收入增速保持两位数","url":"https://stock-news.laohu8.com/highlight/detail?id=2564800554","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564800554?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:46","pubTimestamp":1756817176,"startTime":"0","endTime":"0","summary":"截至2025年9月2日15时,华厦眼科股价为20.45元,较前一交易日下跌0.55元。根据公开信息显示,今年上半年华厦眼科屈光手术业务收入同比增长13.75%,在A股上市眼科医疗企业中保持相对领先的增速水平。行业数据显示,当前屈光手术市场整体增速有所放缓,多家同业企业该业务收入增速已降至个位数。从资金流向来看,华厦眼科当日主力资金净流出1048.54万元,近五个交易日累计净流出1901.03万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/02204652877061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0236","301267"],"gpt_icon":0},{"id":"2562273067","title":"华厦眼科(301267)2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2562273067","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562273067?lang=zh_cn&edition=full","pubTime":"2025-08-26 06:03","pubTimestamp":1756159435,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华厦眼科发布2025年中报。截至本报告期末,公司营业总收入21.39亿元,同比上升4.31%,归母净利润2.82亿元,同比上升6.2%。本报告期华厦眼科公司应收账款体量较大,当期应收账款占最新年报归母净利润比达78.96%。去年的净利率为10.63%,算上全部成本后,公司产品或服务的附加值一般。持有华厦眼科最多的基金为中信建投轮换混合A,目前规模为8.66亿元,最新净值3.2579,较上一交易日上涨0.79%,近一年上涨49.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600008166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"gpt_icon":0},{"id":"2561579742","title":"华厦眼科(301267.SZ):上半年净利润2.82亿元,同比增长6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561579742","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561579742?lang=zh_cn&edition=full","pubTime":"2025-08-24 16:17","pubTimestamp":1756023426,"startTime":"0","endTime":"0","summary":"格隆汇8月24日丨华厦眼科(301267.SZ)公布2025年半年度报告,报告期实现营业收入21.39亿元,同比增长4.31%;归属于上市公司股东的净利润2.82亿元,同比增长6.20%;归属于上市公司股东的扣除非经常性损益的净利润2.78亿元,同比增长2.43%;基本每股收益0.34元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/24161752655239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301267"],"gpt_icon":0},{"id":"2561771252","title":"华厦眼科:发布对外投资管理制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2561771252","media":"金融界快讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561771252?lang=zh_cn&edition=full","pubTime":"2025-08-24 15:33","pubTimestamp":1756020786,"startTime":"0","endTime":"0","summary":"金融界8月24日消息,华厦眼科公告称,为规范公司的对外投资行为,提高投资效益,规避投资所带来的风险,公司制定对外投资管理制度,制度明确了对外投资的审批权限、组织管理机构、决策管理、转让与收回、人事管理、财务管理及审计等内容,并对重大事项报告及信息披露作出规定。\n\n\r\n 责任编辑:钟离","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/24153352654882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301267","BK0236"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765999770168,"stockEarnings":[{"period":"1week","weight":-0.0471},{"period":"1month","weight":-0.097},{"period":"3month","weight":-0.1105},{"period":"6month","weight":0.0263},{"period":"1year","weight":-0.1091},{"period":"ytd","weight":-0.0211}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"21229人(较上一季度增加0.58%)","perCapita":"30545股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":" 华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。报告期内,华厦眼科获得国家眼部疾病临床医学研究中心授予的“中国眼科病理联盟COPA中心级单位”,厦门眼科中心副院长吴护平教授团队的科研课题《重大角膜及眼表疾病的关键诊疗技术和规范建设》斩获“厦门市科学技术进步奖二等奖”,厦门眼科中心业务副院长刘旭阳教授团队的科研课题《眼病的分子遗传学系列研究》获“福建医学科技奖三等奖”及“厦门市科学技术进步三等奖”。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}